Changsatja, S., Kositamongkol, C. ., Thamlikitkul, L. ., Phisalprapa, P. ., & Komonpaisarn, T. . (2025). COST-EFFECTIVENESS ANALYSIS OF ADJUVANT OSIMERTINIB IN RESECTED EGFR-MUTATED EARLY-STAGE NON-SMALL CELL LUNG CANCER IN THAILAND. Proceedings of the International Conference on Public Health, 9(1), 45–67. https://doi.org/10.17501/24246735.2024.9105